Breast Cancer -

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-10-18
Clinical Trial Update: Efficacy and Safety of Combinition of Camrelizumab in Second-line Neoadjuvant Chemotherapy and Adjuvant Therapy [Phase 2]
Phase 2 trial update assessing the efficacy and safety of acombination therapy with camrelizumab in second-line neoadjuvant chemotherapy and…